We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Microchip Device for One Hour Antibiotic Resistance Testing

By LabMedica International staff writers
Posted on 08 Jun 2015
Print article
Image: Schematic of the antibiotic susceptibility testing device. Bacteria are cultured in miniature chambers, each of which contains a filter for bacterial capture and electrodes for readout of bacterial metabolism (Photo courtesy of the University of Toronto).
Image: Schematic of the antibiotic susceptibility testing device. Bacteria are cultured in miniature chambers, each of which contains a filter for bacterial capture and electrodes for readout of bacterial metabolism (Photo courtesy of the University of Toronto).
A novel electrochemical approach – designed to replace growth or fluorescent tests for drug resistance – can determine within one hour whether a culture of bacteria is susceptible to a particular antibiotic.

At present, the rapid determination of antibiotic susceptibility is hindered by the requirement that, in existing devices, bacteria must be pre-cultured for two to three days to reach detectable levels.

To break this bottleneck, investigators at the University of Toronto (Canada) designed a "lab-on-chip" device containing a series of minute flow-through wells patterned onto a glass chip. Each well has the capacity for only two nanoliters of growth medium and has a filter composed of microbeads at the bottom. The bacterial culture is passed through the well together with the antibiotic being tested, and the organisms are trapped by the filter at the bottom of the well. The bacteria accumulate in the wells, where they remain trapped with the antibiotic and the signal molecule resazurin.

Viable bacteria metabolize resazurin into resorufin, changing its electrochemical signature. If the bacteria are killed by the antibiotic, they stop metabolizing resazurin, and the electrochemical signature of the sample does not change. If they are antibiotic-resistant, they continue to metabolize resazurin into resorufin, altering its electrochemical signature. Electrodes built directly into the chip detect this change,

This electrochemical phenotyping approach was shown to be effective with clinically-relevant levels of bacteria and provided results comparable to culture-based analysis. Results, however, were delivered on a much faster timescale, with resistance profiles available after a single hour of incubation.

"Guessing can lead to resistance to these broad-spectrum antibiotics, and in the case of serious infections, to much worse outcomes for the patient," said first author Justin Besant, a graduate research student at the University of Toronto. "We wanted to determine whether bacteria are susceptible to a particular antibiotic, on a timescale of hours, not days. We have a lot of bacteria in a very small space, so our effective starting concentration is much higher, and as the bacteria multiply and convert the resazurin molecule, it is effectively stuck in this nanoliter droplet—it cannot diffuse away into the solution, so it can accumulate more rapidly to detectable levels."

"The electronics for our electrochemical readout can easily fit in a very small benchtop instrument, and this is something you could see in a doctor's office, for example," said Justin Besant. "The next step would be to create a device that would allow you to test many different antibiotics at many different concentrations, but we are not there yet."

The microchip device for assessing antibiotic resistance was described in the May 13, 2015, online edition of the journal Lab on a Chip.

Related Links:

University of Toronto 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.